
UnitedHealth Group, the American insurance giant recently in the spotlight due to the tragic death of UnitedHealthcare CEO Brian Thompson, has landed in yet another controversy—this time involving the Federal Trade Commission (FTC).
A newly released government report has uncovered that UnitedHealth Group, along with other major healthcare companies, has been charging exorbitant markups on prescription drugs, sometimes exceeding 1,000%, even for generic brands.